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More than one billion pounds of pesticides are
used each year in the United States, with more
than 700 million pounds used annually in
agriculture (Donaldson et al. 2002). Recent
studies have demonstrated widespread pesti-
cide exposures for the U.S. population, includ-
ing pregnant women and children (Adgate
et al. 2001; Berkowitz et al. 2003; Bradman
et al. 1997, 2003; Hill et al. 1995; Loewenherz
et al. 1997; Lu et al. 2001; National Center for
Environmental Health 2003; Whyatt et al.
2002), with several studies suggesting that resi-
dent farm families and farm workers have
higher exposures than do other populations
(Curl et al. 2002; Fenske et al. 2002; Lu et al.
2000; McCauley et al. 2001; O’Rourke et al.
2000; Simcox et al. 1999).
In 1993, a National Academy of Sciences
report (National Research Council 1993)
stated that current tolerances for pesticide lev-
els in food may not adequately protect fetuses
and children and that the U.S. Environmental
Protection Agency (EPA) needs to consider
both dietary and nondietary sources of expo-
sures in setting pesticide tolerances. The
National Academy of Sciences called for
research to fill the gaps of information on
exposures and health consequences of pesticide
exposures to the fetus and child.
Exposure of rodent dams during preg-
nancy to certain organophosphate pesticides,
such as chlorpyrifos (Chanda et al. 1995;
Muto et al. 1992), quinalphos (Srivastava et al.
1992), and dimethoate (Srivastava and Raizada
1996), has been associated with decrements in
fetal growth in some studies. Other studies of
the same pesticides (Institoris et al. 1995) and
other organophosphates (Clemens et al. 1990;
Institoris et al. 1995; Spyker and Avery 1977)
have shown no association with fetal growth.
To our knowledge, no animal studies have
examined the relationship of length of gesta-
tion and organophosphate pesticide exposure.
The few studies that have examined the
association of prenatal pesticide exposure and
fetal growth or gestational duration in
humans have also shown conflicting results
(Fenster and Coye 1990; Grether et al. 1987;
Kristensen et al. 1997; Perera et al. 2003;
Restrepo et al. 1990; Savitz et al. 1989;
Thomas et al. 1992; Willis et al. 1993; Xiang
et al. 2000). Only three of these studies used
biomarkers to measure pesticide exposure.
Perera et al. (2003) found that, in residents of
upper Manhattan, New York, increasing levels
of the organophosphate pesticide chlorpyrifos
in umbilical cord blood were associated with
decreased birth weight and birth length but not
with head circumference. Gestational duration
was not examined. Berkowitz et al. (2004)
reported that, in residents of east Harlem, levels
of the urinary metabolite of chlorpyrifos,
3,5,6-trichloro-2-pyridinol (TCPy), were not
associated with decreased birth weight, birth
length, or head circumference or shortened
gestation. However, head circumference was
diminished in the children of women with
low expression of paraoxonase 1 (PON1), an
esterase involved in the detoxification of
organophosphates. Willis et al. (1993) esti-
mated pesticide exposure using plasma choli-
nesterase levels but failed to ﬁnd an association
with birth weight or preterm delivery. An addi-
tional eight studies have estimated prenatal pes-
ticide exposure based either on the mother’s
occupation or location of mother’s residence in
relation to areas where pesticides were sprayed.
Of these, ﬁve studies (Dabrowski et al. 2003;
Kristensen et al. 1997; Restrepo et al. 1990;
Savitz et al. 1989; Xiang et al. 2000) found that
potential exposure of women to pesticides dur-
ing pregnancy was associated with an increased
risk of low birth weight, small for gestational
age (SGA), preterm delivery, or shortened ges-
tation, whereas three studies (Fenster and Coye
1990; Grether et al. 1987; Thomas et al. 1992)
found no association. In general, most studies
have been hampered by their inability to
accurately classify pesticide exposure.
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Although pesticide use is widespread, little is known about potential adverse health effects of
in utero exposure. We investigated the effects of organophosphate pesticide exposure during preg-
nancy on fetal growth and gestational duration in a cohort of low-income, Latina women living in
an agricultural community in the Salinas Valley, California. We measured nonspeciﬁc metabolites
of organophosphate pesticides (dimethyl and diethyl phosphates) and metabolites specific to
malathion (malathion dicarboxylic acid), chlorpyrifos [O,O-diethyl O-(3,5,6-trichloro-2-pyridinyl)
phosphoro-thioate], and parathion (4-nitrophenol) in maternal urine collected twice during preg-
nancy. We also measured levels of cholinesterase in whole blood and butyryl cholinesterase in
plasma in maternal and umbilical cord blood. We failed to demonstrate an adverse relationship
between fetal growth and any measure of in utero organophosphate pesticide exposure. In fact, we
found increases in body length and head circumference associated with some exposure measures.
However, we did ﬁnd decreases in gestational duration associated with two measures of in utero
pesticide exposure: urinary dimethyl phosphate metabolites [βadjusted = –0.41 weeks per log10 unit
increase; 95% conﬁdence interval (CI), –0.75––0.02; p = 0.02], which reﬂect exposure to dimethyl
organophosphate compounds such as malathion, and umbilical cord cholinesterase (βadjusted = 0.34
weeks per unit increase; 95% CI, 0.13–0.55; p = 0.001). Shortened gestational duration was most
clearly related to increasing exposure levels in the latter part of pregnancy. These associations with
gestational age may be biologically plausible given that organophosphate pesticides depress
cholinesterase and acetylcholine stimulates contraction of the uterus. However, despite these
observed associations, the rate of preterm delivery in this population (6.4%) was lower than in a
U.S. reference population. Key words: birth outcomes, birth weight, cholinesterase, dialkyl phos-
phates, fetal growth, gestational age, organophosphates, pesticides, urinary metabolites. Environ
Health Perspect 112:1116–1124 (2004). doi:10.1289/ehp.6789 available via http://dx.doi.org/
[Online 11 March 2004]The purpose of the present analysis is to
determine whether organophosphate pesticide
exposure, as assessed by biologic markers, is
associated with poorer fetal growth and short-
ened length of gestation in a cohort of pregnant
women living in an agricultural community in
the Salinas Valley of California (Eskenazi et al.
2003). The Salinas Valley is located southeast
of San Francisco and runs approximately
60 miles within Monterey County. This area is
often referred to as the “nation’s salad bowl,”
growing primarily lettuce, broccoli, other cole
crops, strawberries, artichokes, and grapes.
Approximately 500,000 lb of organophosphate
pesticides are applied annually in the Salinas
Valley (California EPA 2002).
Materials and Methods
Participants and recruitment. The CHAMA-
COS (Center for the Health Assessment of
Mothers and Children of Salinas) project, a
component of the Center for Children’s
Environmental Health Research at the
University of California, Berkeley, is a longi-
tudinal birth cohort study of the effects of
pesticides and other environmental exposures
on the health of pregnant women and their
children living in the Salinas Valley. Pregnant
women entering prenatal care at Natividad
Medical Center, a county hospital located in
the town of Salinas, or at one of ﬁve centers
of Clinica de Salud del Valle de Salinas
(located in Castroville, Salinas, Soledad, and
Greenfield) were screened for eligibility over
1 year between October 1999 and October
2000. Clinica de Salud del Valle de Salinas
is a network of community clinics located
throughout the Salinas Valley and serving a
low-income population, many of whom are
farm workers.
Eligible women were ≥ 18 years of age, < 20
weeks gestation at enrollment, English or
Spanish speaking, Medi-Cal eligible, and plan-
ning to deliver at the Natividad Medical Center.
Of 1,130 eligible women, 601 (53.2%)
agreed to participate in this multiyear study.
Women who declined to participate were
similar to study subjects in age and parity
but were more likely to be English speaking
and born in the United States and less likely
to be living with agricultural field workers.
After losses due to miscarriage, moving, or
dropping from the study before delivery,
birth weight information was available for
538 women. We excluded from these analyses
women with gestational or preexisting dia-
betes (n = 26), hypertension (n = 15), twin
births (n = 5), or stillbirths (n = 3). We also
excluded one woman for whom birth weight
information was out of range (< 500 g).
Eleven infants diagnosed with congenital
anomalies at birth [International Classiﬁcation
of Diseases, 9th Revision (ICD-9; 1989) codes
740–759] were included in the final sample
because their exclusion did not materially
affect the results. The final sample size was
488. Written informed consent was obtained
from all participants, and the study was
approved by the institutional review boards.
Interview and medical record abstraction.
Women were interviewed twice during preg-
nancy and again shortly after delivery. The
baseline interview occurred at a mean of
13 weeks gestation (range, 4–29 weeks), and
the second interview occurred at a mean of
26 weeks gestation (range, 18–39 weeks).
Interviews were conducted in English or
Spanish by bilingual, bicultural interviewers.
Demographic information obtained dur-
ing the baseline interview included maternal
age, family income, the number of people
supported by this income, country of birth,
and number of years lived in the United
States. Information on alcohol, tobacco, drug
and caffeine use, and agricultural work was
obtained at each interview. Information about
previous pregnancies and any medical con-
ditions, medications, or pregnancy complica-
tions was obtained by interview and conﬁrmed
by medical records. Medical records from pre-
natal visits and delivery were abstracted by a
registered nurse.
Pesticide exposure measurement. Exposure
to organophosphate pesticides was assessed in
three ways: a) by measuring organophosphate
dialkyl phosphate metabolites in maternal urine
during pregnancy; b) by measuring seven differ-
ent pesticide-speciﬁc metabolites in maternal
urine during pregnancy; and c) by measuring
cholinesterase (ChE) in whole blood and buty-
ryl cholinesterase (BChE) in plasma collected
from mothers during pregnancy and at delivery
and from the umbilical cord.
For dialkyl phosphate metabolites, spot
urine samples were collected from the pregnant
women at the time of the two pregnancy inter-
views. Urine specimens were aliquoted and
stored at –80°C until shipment to the Centers
for Disease Control and Prevention (CDC;
Atlanta, GA) for analysis of dialkyl phosphate
and pesticide-speciﬁc metabolite levels.
Six dialkyl phosphate metabolites were
measured in the urine samples using gas
chromatography and mass spectrometry and
quantified using isotope dilution calibration
(Bravo et al. 2002). The dialkyl phosphates
measured were dimethylphosphate, dimethyl-
dithiophosphate, dimethylthiophosphate,
diethylphosphate, diethyldithiophosphate,
and diethylthiophosphate. Approximately
80% of the organophosphate pesticides used
in the Salinas Valley devolve to one or more
of these metabolites, which are excreted in
urine. The most commonly used pesticides in
this region that devolve to dialkyl phosphates
are presented in Table 1.
Quality control (QC) procedures were
conducted on laboratory and field samples.
Laboratory QC was established by repeat
analysis of two in-house urine pools enriched
with known amounts of pesticide residues
whose target values and confidence limits
were previously determined. An analytical run
was considered “out-of control” if the QC
value failed to meet the requirements of the
Westgard QC multirules (Westgard 2002).
Data were not reported from runs considered
“out-of-control.” Mean recoveries for labora-
tory QC samples ranged from 98 to 105%,
and the coefﬁcients of variation (CV) ranged
from 11 to 15%. Field QC was conducted by
blindly inserting QC samples among the
study samples in the ﬁeld. These QC materi-
als were thawed in the field, aliquoted into
regular sample vials, and shipped with the
samples on dry ice to CDC. The concentra-
tions of the field QC materials, which were
blinded to CDC analysts, generally agreed
well with the spike concentrations (recovery
and CV ranged from 94 to 103% and from
4.3 to 8.7%, respectively), indicating little
contamination and/or degradation during the
sampling procedures and further establishing
the validity of the analytic measurements
(Bravo et al., in press).
Because dialkyl phosphates originate from
more than one organophosphate pesticide,
quantities of the six metabolites were con-
verted to molar concentration (nanomoles per
liter) and summed to obtain the total concen-
trations of dialkyl phosphate metabolites for
each woman. This provided an estimate of
total organophosphate exposure for each indi-
vidual at each of the two measurement times.
The three dimethyl phosphate metabolites and
three diethyl phosphate metabolites were also
summed to obtain total concentrations of
dimethyl and diethyl phosphate metabolites.
For eight women, the level for one of the six
metabolites was not readable because of ana-
lytic interference. Because metabolites within
each group (i.e., diethyl or dimethyl phos-
phates) were highly correlated, the missing val-
ues were imputed using regression analysis to
predict the missing metabolite level based on
the other metabolites levels for that woman at
that time point. Metabolite levels below the
limit of detection (LOD) were given the value
of the LOD divided by the square root of two
(Hornung and Reed 1990).
Creatinine concentrations in urine were
determined using a commercially available diag-
nostic enzyme method (Vitros CREA slides;
Ortho Clinical Diagnostics, Raritan, NJ). Urine
samples with creatinine levels < 10 mg/dL
were considered too dilute for accurate analy-
sis, and one measurement for one woman was
excluded because of low creatinine levels.
Total dialkyl phosphate and dimethyl
phosphate metabolite levels were available for
485 women, and diethyl phosphate metabolite
levels were available for 486 women.
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spot urine samples were analyzed using analytic
and QC procedures similar to those used for
the dialkyl phosphate metabolites (Olsson et al.
2003). The metabolites measured were mala-
thion dicarboxylic acid (MDA; derived from
malathion); 4-nitrophenol (PNP; derived from
methyl parathion, parathion, and other non-
pesticide chemicals); TCPy (from chlorpyrifos
and chlorpyrifos methyl); 2-diethylamino-
4-hydroxy-6-methylpyrimidine (DEAMPY;
from pirimiphos methyl); 2-isopropyl-4-methyl-
6-hydroxypyrimidine (IMPY; from diazinon);
3-chloro-4-methyl-7-hydroxycoumarin
(CMHC; from coumaphos and coumaphos
methyl); and 5-chloro-1-isopropyl-3-hydroxytri-
azole (CIT; from isazophos and isazophos
methyl). With the exception of PNP, all of these
metabolites derive from parent organophosphate
pesticide compounds alone (Table 1). As with
dialkyl phosphates, metabolite levels below the
LOD were given the value of the LOD divided
by the square root of two.
Speciﬁc metabolite levels were available for
482 women for six metabolites and, because of
technical problems, for 382 women for the
metabolite MDA.
For cholinesterase, because organophos-
phate pesticides at high doses are known to
depress acetylcholinesterase, we measured ChE
(or whole blood ChE) and BChE (or plasma
ChE) in maternal and umbilical cord blood.
Blood was collected from mothers at the time
of the second pregnancy interview and in the
hospital before delivery. Umbilical cord blood
was collected by delivery room staff.
Blood samples were analyzed for ChE and
BChE using a modiﬁcation of the Wilson et al.
(2002) microtiter-plate–adapted assay based on
the original Ellman procedure (Ellman et al.
1961). Blood samples were stabilized immedi-
ately at the time of collection by diluting them
1:10 with 0.1 M NaPO4 buffer (pH 8.0) con-
taining 1% Triton X-100. Processed samples
were stored at –80°C before being shipped
on dry ice to the University of Washington,
Seattle, for analysis. At the time of assay,
the samples were thawed, mixed thoroughly,
and diluted 1:25 with 0.1 M NaPO4 buffer
(pH 8.0) without Triton X-100 for a final
1:250 dilution of sample. One hundred micro-
liters of 1:250 diluted samples were distributed
to the wells of a microtiter plate. The reaction
was initiated with 100 µL of a 2× assay mix of
either ChE or BChE substrate, resulting in
1 mM final substrate. Assays were followed
continuously at ambient temperature (23°C) at
412 nm for 10 min in a SpectraMax PLUS
Microplate Reader (Molecular Devices Corp,
Sunnyvale, CA). The initial linear rates of
hydrolysis were obtained in units of optical
density per minute. The path length for each
well of the plate was measured immediately
after the reaction, and rates were converted to
rates of change in A412 per minute, and then
to units of enzyme activity per milliliter. Each
assay was run in triplicate. If the rate values
varied by more than 5%, the sample was reana-
lyzed. A standard ChE sample supplied by the
laboratory of B. Wilson (Departments of
Environmental Toxicology and Avian Sciences,
University of California, Davis, CA) was used
to assure interlaboratory standardization.
ChE and BChE analysis was performed
on all samples available and stabilized for
this analysis, for a total of 292 women during
pregnancy, 357 women at delivery, and
340 umbilical cord bloods.
Definition of outcomes. Infant birth
weight, crown–heel length, and head cir-
cumference were obtained from hospital
delivery logs and medical records. Infant
ponderal index, a measure of proportionality
of growth, was calculated as (birth weight
in grams × 100)/(length in centimeters)3.
Gestational age was obtained from medical
records and was based on ultrasound proce-
dures for 25% of women. Because ultrasound
estimates of gestational age may mask
intrauterine growth retardation, we also esti-
mated gestational age based on the woman’s
self-reported date of last menstrual period.
Results were similar using both methods, and
the medical record gestational age is reported,
except where noted.
Low birth weight was deﬁned as < 2,500 g.
Preterm delivery was defined as birth at less
than 37 completed weeks of gestation. An
SGA birth was deﬁned as birth weight < 10th
percentile for gestational age according to eth-
nicity (Mexican American or non-Hispanic
white), parity, and infant sex from national
data (Overpeck et al. 1999).
Data analysis. Linear regression models
were used to test for associations between expo-
sure measurements and length of gestation,
birth weight, length, head circumference, and
ponderal index. Logistic regression was used to
test for associations between exposure measure-
ments and low birth weight, preterm delivery,
and SGA births.
ChE and BChE were analyzed as continu-
ous variables. Dialkyl phosphate metabolites
were analyzed as continuous variables on a
log10 scale. The pesticide-specific metabolite
levels were analyzed as categorical variables
because of the large proportion of women
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Table 1. Number of women with measurements and percentage detectable, median values, and ranges (average of two measurements) of various organophosphate
exposure measures during pregnancy: CHAMACOS study, Salinas Valley, California, 2000–2001.
Percent >
Marker of exposure Parent compounds or class No. LOD LODa Median (range)b Sample measured
Dialkyl phosphate metabolites (nmol/L)
Dimethyl phosphates Malathion, oxydemeton-methyl, 486 0.08–1.2 99.8 101 (5–6,587) Urine
dimethoate, naled, methidathionc
Diethyl phosphates Diazinon, chlorpyrifos, disulfoton 485 0.05–0.8 99.8 22 (2–680) Urine
Total dialkyl phosphates All of above 485 0.05–1.2 99.8 136 (10–6,854) Urine
Pesticide-speciﬁc metabolites (µg/L)
MDA Malathion 382 0.29 30.1 0.2 (0.2–28.9) Urine
TCPy Chlorpyrifos, chlorpyrifos methyl 482 0.26 76.3 3.3 (0.2–56.1) Urine
PNP Methyl parathion, parathion, EPNd 482 0.14 54.4 0.5 (0.1–34.7) Urine
DEAMPY Pirimiphos methyl 482 0.21–0.22 5.0 0.2 (0.1–14.9) Urine
IMPY Diazinon 482 0.69 2.4 0.5 (0.5–7.1) Urine
CMHC Coumaphos, coumaphos methyl 482 0.18 0.7 0.1 (0.1–0.3) Urine
CIT Isazophos, isazophos methyl 482 1.50 10.9 1.1 (1.1–36.0) Urine
Cholinesterase (µmol/min/mL)
ChE Organophosphates and 340 NA NA 3.8 (1.7–6.1) Whole blood (cord)
n-methyl carbamates 357 NA NA 5.1 (0.7–10.2) Whole blood (maternal delivery)
292 NA NA 5.7 (2.2–10.9) Whole blood (maternal pregnancy)
BChE Organophosphates and 340 NA NA 1.2 (0.6–2.7) Plasma (cord)
n-methyl carbamates 357 NA NA 1.4 (0.6–3.9) Plasma (maternal delivery)
292 NA NA 1.4 (0.3–2.7) Plasma (maternal pregnancy)
NA, Not applicable.
aPercentage of women with metabolite levels above the LOD for at least one measurement during pregnancy. bUrinary metabolites: average of two pregnancy measurements, not
adjusted for creatinine. cOnly parent compounds with annual use in Salinas Valley > 10,000 lb are listed. dPNP may also derive from nonpesticide chemicals used in industrial processes.with nondetectable levels. For each pesticide-
specific metabolite, women were assigned
to one of three groups: no detectable levels
(referent group), detectable levels below the
median of the detectable levels, and detectable
levels above the median. Associations with
all urinary metabolites (dialkyl phosphates
and pesticide-specific metabolites) were
analyzed both adjusted and unadjusted for
creatinine.
For analysis, the two pregnancy measure-
ments of each urinary metabolite were aver-
aged for each woman. This method was
justiﬁed because there was no evidence of trend
over time in metabolite levels and because
there was a large within person variability in
the metabolite measures, which was reduced
by using the average. In addition, average
metabolite level can be viewed as an approxi-
mate measure of cumulative pesticide dose
over pregnancy. For speciﬁc metabolites, if a
woman was below the LOD for both meas-
urements, she was classiﬁed as below LOD for
the average. If she was above the LOD at
either or both measurements, her measure-
ments were averaged and classiﬁed in relation
to the median.
To identify “critical windows” of fetal
development when exposure may have a
greater impact, we analyzed the associations
of outcomes and metabolite levels measured
during moving 6-week windows of pregnancy
(e.g., 5–10 weeks, 6–11 weeks, 7–12 weeks)
using a series of multiple regression analyses.
Six weeks was chosen because this time frame
ensured a sample size of at least 100 women
in each interval. When a woman had two
measurements within a single interval, one
measurement was randomly selected.
For analyses using gestational age as an
outcome, metabolite levels were dropped for
19 women whose measurements occurred
after 30 weeks gestation (the gestational dura-
tion of the earliest birth) to prevent a “sur-
vival” bias associated with a late metabolite
measurement.
All models of birth weight, length, head
circumference, and ponderal index were
adjusted for gestational age and gestational age
squared. We selected potential confounders for
the multivariate models based on associations
reported in the literature, and we included in
the models those that changed the coefﬁcient
of exposure by 10% or more. The models
included continuous variables for maternal age,
pregnancy weight gain, and week of initiating
prenatal care and categorical variables for par-
ity, infant sex, mother’s country of birth, body
mass index (BMI), and family income. Poverty
level was calculated by dividing household
income by the number of people supported by
that income and comparing it with federal
poverty thresholds (U.S. Census Bureau 2000).
Smoking, alcohol, and illicit drug use were not
included in the models because very few
women reported use and controlling for these
variables did not alter the results. The more
commonly reported exposure to environmental
tobacco smoke and caffeinated beverages also
did not alter the relationship of pesticide
metabolites and birth outcome and were not
included. Additional analyses were conducted
including history of low birth weight and his-
tory of preterm delivery, but these covariates
were dropped from the ﬁnal analyses because
they did not affect the results. All analyses were
conducted using Stata, version 8.0 (Stata
Corporation, College Station, TX).
Results
Table 2 describes the sociodemographic char-
acteristics of the population. The women aver-
aged 25 years of age (SD = 5); two-thirds were
multiparous, 80% were married, 79% had
not graduated from high school, 58% were
overweight or obese, 88% preferred to speak
Spanish, and 84% were born in Mexico, with
more than half residing in the United States
for < 5 years (data not shown). Almost all of
the women were living within 200% of the
poverty level. Very few women reported smok-
ing (6%), drug use (2%), or alcohol consump-
tion (1%) during pregnancy. Approximately
28% of the women had worked in the ﬁelds
during the pregnancy, and another 14% had
worked at other jobs in agriculture, including
packing shed, nursery, and greenhouse work.
Overall, 85% of the women had agricultural
workers living in their homes during their
pregnancy (data not shown).
Table 1 shows the percentage of women
with detectable levels of each urinary metabo-
lite during pregnancy as well as the median val-
ues and ranges. The median dimethyl, diethyl,
and total dialkyl phosphate metabolite levels
for the study population were 101 nmol/L,
22 nmol/L, and 136 nmol/L, respectively.
Only one woman had no detectable levels
of dialkyl phosphate metabolites in urine dur-
ing pregnancy. The percentages of women
with detectable levels of MDA, TCPy, and
PNP during pregnancy were 30, 77, and 54%,
respectively. The median level for MDA was
0.2 µg/L, for TCPy was 3.3 µg/L, and for PNP
was 0.5 µg/L. Because only a small percentage
of women had levels above the LOD for the
pesticide-specific metabolites DEAMPY,
IMPY, CMHC, and CIT, we did not analyze
their associations with birth outcomes.
The mean levels of ChE were 5.2 µmol/
min/mL in maternal blood during pregnancy,
5.7 µmol/min/mL in maternal blood imme-
diately before delivery, but somewhat lower at
3.8 µmol/min/mL in umbilical cord blood.
For BChE, the mean levels were similar for all
three. Maternal dialkyl phosphate metabolite
levels and ChE levels collected concurrently at
the second pregnancy interview were not
correlated (Pearson r = 0.02, p = 0.71), and a
small positive rather than the expected nega-
tive correlation was seen between average
dialkyl phosphate metabolite levels during
pregnancy and predelivery maternal blood
(Pearson r = 0.11, p = 0.04) and umbilical
cord ChE levels (Pearson r = 0.13, p = 0.02).
The mean (± SD) duration of gestation was
38.9 ± 1.7 weeks; mean birth weight was
3,449 ± 516 g; mean body (crown–heel) length
was 50.2 ± 2.7 cm; mean head circumference
was 34.1 ± 1.5 cm; and mean ponderal index
was 2.7 ± 0.3 g/m3. A total of 3.7% (n = 18) of
children were born of low birth weight; 4.8%
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Table 2. Demographic characteristics of CHAMA-
COS study population, Salinas Valley, California,
2000–2001 (n = 488).
Characteristics No. (%)
Age (years)
18–24 237 (48.6)
25–29 151 (30.9)
30–34 71 (14.5)
≥ 35 29 (5.9)
Parity
0 162 (32.5)
≥ 1 336 (67.5)
Education
< 6th grade 205 (42.0)
7th–12th grade 180 (36.9)
Completed high school 103 (21.1)
Marital status
Married/living as married 391 (80.1)
Single 97 (19.9)
Preferred language
Spanish 429 (87.9)
English 30 (6.1)
Both 24 (4.9)
Other 5 (1.0)
Country of birth
Mexico 409 (83.8)
United States 68 (13.9)
Other 11 (2.3)
Family income
≤ Poverty level 282 (61.3)
Within 200% of poverty level 161 (35.0)
> 200% of poverty level 17 (3.7)
Body mass index (kg/m2)
Underweight (< 18.5) 176 (37.6)
Normal (18.5–24.9) 194 (41.5)
Overweight (25–29.9) 2 (0.4)
Obese (> 30) 96 (20.5)
Pregnancy weight gain (lbs)
< 25 159 (32.6)
25–35 173 (35.5)
> 35 156 (32.0)
Smoked during pregnancy
Yes 30 (6.1)
No 458 (93.9)
History of preterm/low-birth-weight delivery
Not applicable 162 (37.6)
Neither 217 (50.3)
Preterm only 14 (3.2)
Low birth weight only 17 (3.9)
Both 21 (4.9)
Work status during pregnancy
Not working 170 (35.9)
Working in ﬁelds 133 (28.1)
Other agricultural work 65 (13.7)
Other work (not agricultural) 105 (22.2)
Children’s Health | Prenatal OP pesticide exposure and fetal growth(n = 23) were SGA births, and 6.6% (n = 32)
were preterm.
Table 3 presents the adjusted regression
results for dialkyl phosphate metabolite levels
and pesticide-specific metabolite levels with
measures of fetal growth and length of gestation.
After adjusting for covariates, a 10-fold increase
(i.e., one log-unit increase) in average dialkyl
phosphate metabolite concentration was associ-
ated with an increase in infant’s body length of
0.52 cm (p = 0.06), and in head circumference
of 0.32 cm (p = 0.03). Figure 1A–B indicates
that these positive associations of dialkyl phos-
phate metabolite levels are related to exposure
throughout the gestation period, although
rarely signiﬁcantly at any point for body length.
Similar increases in body length and head cir-
cumference were seen when dimethyl and
diethyl phosphate metabolites were examined
separately, although these increases were not
statistically signiﬁcant (Table 3).
As shown in Table 3, a 10-fold increase in
average dimethyl but not diethyl phosphate
metabolites was associated with a decrease
of 3 days in gestational duration (p = 0.02).
Figure 1C shows that only after 22 weeks of
gestation do increasing levels of dimethyl phos-
phate metabolites have a significant adverse
association with gestational duration.
Dimethyl, diethyl, and total dialkyl phos-
phate metabolite levels were not associated
with birth weight or infant ponderal index and
were also unrelated to risk of preterm delivery,
low birth weight, and SGA births. The ﬁnd-
ings of increased head circumference and
decreased gestational duration persisted when
metabolite levels were controlled for creatinine,
but the ﬁnding of increased body length did
not (data not shown).
No adverse associations were found
between MDA or TCPy and parameters of
fetal growth or gestational age. Increased head
circumference was seen in infants of women
with PNP levels above the median (β =
0.29 cm, p = 0.06) when compared with
women with no detectable levels. Women
with levels of PNP below the median also
showed increased length (β = 0.60 cm,
p = 0.03) compared with women with no
detectable levels, but this effect was not
observed in women with levels above the
median. Borderline significant associations
were seen between PNP and decreasing gesta-
tional age (β = –0.37 weeks, p = 0.06) and
ponderal index (β = –0.08 g/cm3, p = 0.06),
but only in the group below the median.
However, associations seen with PNP should
be viewed with caution because PNP may
derive from compounds other than parathion
(Table 1).
The associations between ChE levels in
umbilical cord blood and parameters of fetal
growth and length of gestation are shown in
Table 4. Lower levels of ChE in umbilical cord
blood were associated with signiﬁcantly shorter
length of gestation, averaging 0.34 weeks (p =
0.001) for each unit decrease in ChE (in micro-
moles per minute per milliter; range of ChE in
cord blood is 4.4 units). Decreasing levels of
ChE in umbilical cord blood were also associ-
ated with increased risk of preterm delivery
[adjusted odds ratio (OR) = 2.3; 95% conﬁ-
dence interval (CI), 1.1–4.8; p = 0.02] and low
birth weight (adjusted OR = 4.3; 95% CI,
1.1–17.5; p = 0.04); however, 6 of the 11 low
birth weight infants were also preterm (data not
shown). Lower levels of ChE in maternal blood
at delivery were associated with decreased
gestational duration, but only when the esti-
mate based on last menstrual period was used
(β = 1.1 days, p = 0.04; data not shown). Lower
ChE levels in maternal blood collected earlier in
pregnancy were not associated with gestational
duration but were somewhat associated with an
increased risk of preterm delivery (OR = 1.6;
95% CI, 1.0–2.5; p = 0.06; data not shown).
Neither maternal nor umbilical cord ChE levels
were associated with any other parameters of
fetal growth. BChE levels in maternal and
umbilical cord blood were not associated with
any birth outcome.
Discussion
We found clear decreases in gestational dura-
tion associated with two measures of in utero
pesticide exposure: levels of metabolites of
dimethyl phosphate pesticide compounds and
whole blood ChE. Shortened gestational
duration was most clearly related to increasing
exposure levels in the latter part of pregnancy.
However, the results of this study failed to
demonstrate an adverse relationship between
fetal growth and in utero organophosphate
pesticide exposure as assessed by multiple
measures of exposure, including plasma and
whole blood cholinesterase, urinary dialkyl
phosphate metabolites, and pesticide-speciﬁc
metabolites of parathion, malathion, and
chlorpyrifos. In fact, we found increases in
length and head circumference associated
with some of these measures.
Our results are consistent with those
of Berkowitz et al. (2004), who found no
adverse relationship between any measures of
fetal growth or length of gestation and maternal
urinary levels of TCPy, the metabolite of the
diethyl organophosphate pesticide chlorpyrifos.
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Table 3. Association of average urinary metabolites of organophosphate pesticides measured at two points during pregnancya with length of gestation and fetal
growth: CHAMACOS study, Salinas Valley, California, 2000–2001.
Length of gestation (weeks)c Birth weight (g)d Length (cm)d Head circumference (cm)d Ponderal index (g/cm3)d
Metabolite No.b β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value
Dialkyl phosphate metabolites 
(nmol/L, log10 scale)
Dimethyl phosphates 485 –0.41 (–0.75––0.07) 0.02** 41 (–40–122) 0.32 0.42 (–0.07–0.91) 0.09* 0.25 (–0.02–0.52) 0.07* –0.03 (–0.10–0.04) 0.45
Diethyl phosphates 486 –0.16 (–0.53–0.22) 0.41 52 (–40–144) 0.26 0.40 (–0.15–0.94) 0.16 0.28 (–0.02–0.59) 0.07* –0.01 (–0.09–0.07) 0.74
Total dialkyl phosphates 485 –0.20 (–0.55–0.15) 0.27 42 (–46–131) 0.35 0.52 (–0.01–1.05) 0.06* 0.32 (0.03–0.62) 0.03** –0.04 (–0.12–0.04) 0.28
Pesticide-speciﬁc 
metabolites (µg/L)
MDA
No detectable levels 233 Referent Referent Referent Referent Referent
Detectable levels < median 74 –0.13 (–0.55–0.30) 0.55 –45 (–154–63) 0.41 –0.53 (–1.18–0.11) 0.11 –0.16 (–0.52–0.19) 0.37 0.05 (–0.05–0.14) 0.33
Detectable levels ≥ median 75 –0.21 (–0.62–0.20) 0.32 56 (–49–161) 0.29 0.14 (–0.48–0.76) 0.66 0.11 (–0.24–0.46) 0.53 0.02 (–0.07–0.12) 0.60
TCPy
No detectable levels 41 Referent Referent Referent Referent Referent
Detectable levels < median 220 –0.17 (–0.74–0.40) 0.55 –6 (–138–126) 0.93 0.09 (–0.70–0.87) 0.83 0.06 (–0.37–0.49) 0.78 –0.01 (–0.12–0.11) 0.89
Detectable levels ≥ median 221 –0.06 (–0.63–0.51) 0.84 27 (–106–159) 0.69 0.44 (–0.35–1.22) 0.27 0.04 (–0.39–0.47) 0.85 –0.04 (–0.16–0.08) 0.50
PNP
No detectable levels 124 Referent Referent Referent Referent Referent
Detectable levels < median 179 –0.37 (–0.76–0.02) 0.06* 34 (–57–125) 0.46 0.60 (0.06–1.13) 0.03** 0.18 (–0.12–0.48) 0.23 –0.08 (–0.16–0.0) 0.06
Detectable levels ≥ median 179 0.18 (–0.21–0.57) 0.36 49 (–42–140) 0.29 0.41 (–0.13–94) 0.14 0.29 (–0.01–0.58) 0.06* –0.03 (–0.11–0.05) 0.48
aUrinary metabolite levels are not adjusted for urinary creatinine concentration. bNumbers vary slightly for different outcomes due to missing data. cModels adjusted for timing of urine
collection, timing of entry into prenatal care, maternal age, parity, country of birth, and poverty level. dModels adjusted for timing of urine collection, timing of entry into prenatal care,
maternal age, parity, infant sex, country of birth, weight gain, BMI, poverty level, gestational age, and (gestational age)2.
*p < 0.10; **p < 0.05.Our results are also consistent with those of
Willis et al. (1993), who reported no associa-
tion of either fetal growth or length of gestation
and maternal plasma BChE levels. However,
our results differ from those of Perera et al.
(2003), who reported decreased birth weight
and length in association with blood measure-
ments of the parent compound chlorpyrifos in
pregnant residents of New York City.
Disparities among study results may be
due, in part, to differences in exposure meas-
urements. For example, in our study and in the
study by Willis et al. (1993), there was no asso-
ciation between fetal outcome measures and
plasma BChE levels, but we did observe clear
associations with shortened gestation using
whole blood ChE as the measure of exposure.
Whole blood ChE reﬂects exposure to organo-
phosphate and n-methyl carbamate pesticides
over a few months, whereas plasma BChE
reflects more immediate exposure (Karlsen
et al. 1981; Lessenger and Reese 1999; Sanz
et al. 1991; U.S. EPA 2000; Yuknavage et al.
1997). In our study, as in the study by Willis
et al. (1993), we used the absolute level of
cholinesterase as an indicator of exposure,
rather than the change from a preexposure
baseline level, as is typically used in occupa-
tional monitoring of pesticide poisoning.
There is some evidence that absolute ChE
measurements can be effective in establishing
effects of organophosphate pesticide exposures.
For example, this approach was used to show
a significant inhibition of ChE in children
exposed to rain water runoff from a large crop-
dusting airport (McConnell et al. 1999).
Both the present study and the study by
Berkowitz et al. (2004) found no association
of the metabolite TCPy and fetal growth or
length of gestation, although our methods of
chemical analysis may have differed. Berkowitz
et al. (2004) reported a detection frequency of
42% versus our report of 77%. Their lower
detection frequency is not surprising given that
our LOD was nearly 50 times lower. However,
the median TCPy level in these New York
City residents was more than twice (7.5 vs.
3.3 µg/L) that of our residents who lived in an
agricultural community where > 50,000 lb of
chlorpyrifos were applied annually to agricul-
tural ﬁelds. The median level in both studies
was considerably higher than the median
(1.7 µg/L) from a stratified random sample
of the U.S. population participating in the
National Health and Nutrition Examination
Survey (NHANES; National Center for
Environmental Health 2003) and analyzed by
the same CDC laboratory as samples in our
study. In addition, the present study and both
New York City studies (Berkowitz et al. 2004;
Perera et al. 2003) straddled the time frame of
the U.S. EPA ban on chlorpyrifos use in the
home, beginning 1 January 2001 (U.S. EPA
2000). Although chlorpyrifos exposure from
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Figure 1. Adjusted regression coefﬁcients (solid lines) and 95% CIs (dashed lines) for the association of urinary
dialkyl phosphate metabolites (log10 scale) and (A) crown–heel length, (B) head circumference, and (C) the
association of dimethyl phosphates and length of gestation according to timing of exposure during pregnancy.
Regression coefﬁcients were adjusted to control for timing of urine collection, week of entry to prenatal care,
maternal age, parity, infant sex, maternal BMI, maternal weight gain, country of birth, and poverty level.
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contribution to exposure in New York City,
very few of the home pesticides found in the
homes of CHAMACOS participants con-
tained chlorpyrifos. Possible sources of chlor-
pyrifos exposure to our population include
diet, residues in the home from past home pes-
ticide use, or agricultural use, which was largely
unaffecated by the U.S. EPA regulation.
Measurements of pesticides in blood, as
in the study by Perera et al. (2003), is a direct
measure of exposure to the parent compound
and may more accurately reﬂect the dose to the
target organ than measurements of metabo-
lites in urine (Barr et al. 1999; Needham et al.
1995).
Although blood measurements may be
preferable in certain cases, estimating organo-
phosphate pesticide exposure with urinary
levels of dialkyl phosphate metabolites has
an important advantage beyond the ease of
specimen collection. The dialkyl phosphate
metabolites reﬂect exposure to about 80% of
the organophosphate pesticides used in the
Salinas Valley (California EPA 2000), although
a number of highly used organophosphate pes-
ticides (e.g., acephate) do not devolve into these
urinary metabolites. Although dialkyl phos-
phate metabolites measurements do not allow
differentiation between exposures that result
from more or from less toxic pesticides [e.g.,
oxydemeton-methyl is orders of magnitude
more acutely neurotoxic than is malathion;
both may devolve to dimethyl metabolites
(Olsson et al. 2003; Wessels et al. 2003)], they
are an excellent nonspecific but integrated
measure of exposure to a class of pesticides. We
have partially addressed this limitation by
complementing measurements of dialkyl phos-
phate metabolites with available analyses of
pesticide-speciﬁc organophosphate metabolites.
However, currently, there are no analytical
methods for measurement of speciﬁc exposure
to many important organophosphate pesticides
(e.g., oxydemeton-methyl) in urine or in
blood, and even some of the ones we can meas-
ure (e.g., PNP) may derive from other sources
in addition to the pesticide of interest. Thus,
measurement of dialkyl phosphate metabolites
may be the only biologic measure currently
available to characterize and integrate exposure
to multiple organophosphate pesticides that
may originate from different sources.
Current biomarkers used to assess pesticide
exposure, whether in blood or urine, can result
in exposure misclassiﬁcation. Organophosphate
pesticides and their metabolites have a short
residence time in the body [Abu-Qare et al.
2001; Garﬁtt et al. 2002; Grifﬁn et al. 1999;
World Health Organization (WHO) 1996].
Exposures may be transient and highly vari-
able. In fact, we found that the within-person
standard deviation for the two urinary dialkyl
phosphate metabolite measurements was
approximately three times larger than the
between-person standard deviation. Thus,
measurements conducted on one [as in the
studies of Berkowitz et al. (2004) and Perera
et al. (2003)] or two (as in the present study)
blood or urine specimens during pregnancy
may not accurately reﬂect exposures over the
entire pregnancy. Furthermore, the interrela-
tionship of these different exposure measure-
ments has not been well studied and may
differ in pregnancy.
Understanding the mechanism of pesticide
exposure and shortened gestational duration
will require further examination of the interre-
lationship of different exposure measurements.
For example, we found no correlation between
concurrent measurements of dialkyl phosphate
metabolites in urine and ChE in blood, and
we found an unexpected small positive rela-
tionship between ChE and average dialkyl
phosphate levels over pregnancy. The absence
of a negative correlation between dialkyl phos-
phate metabolites and ChE is perhaps partially
caused by substantial measurement error in
both measures. The fact that decreases in ges-
tational age were seen with both dimethyl
phosphates and cord ChE may reflect a true
association of organophosphate exposure and
length of gestation, even though measurement
error prevents these two markers of exposure
from being negatively correlated with each
other. An additional explanation for the lack
of expected correlation between ChE and
dialkyl phosphate metabolites is that dialkyl
phosphate metabolites are speciﬁc to organo-
phosphate compounds, whereas ChE levels
may reﬂect exposure to both organophosphate
and n-methyl carbamate pesticides. n-Methyl
carbamate use in Monterey County in the year
this study was conducted exceeded 100,000 lb
(California EPA 2002) and may be a major con-
tributor to ChE levels in this population. We
note, however, that at least among the women
who delivered prematurely, we found the antici-
pated negative correlation between dialkyl phos-
phate metabolites and ChE levels (r = –0.45,
p = 0.05). Thus, population correlations may be
masking associations in high-risk groups.
Despite difﬁculties in exposure assessment,
the associations between pesticide exposure
measures and gestational duration are quite
compelling. The relation of ChE and short-
ened gestation may be biologically plausible.
Cholinergic nerves play a significant role in
the control of the uterine musculature and
myometrium. Acetylcholine stimulates con-
traction of the uterus and dilates its arterial
supply (Papka et al. 1999). Thus, an inhibi-
tion of acetyl ChE could produce an accu-
mulation of acetylcholine in the neuronal
junctions and hence the overstimulation of
cholinergic ﬁbers resulting in premature initia-
tion of labor. Our results suggest that exposure
to dimethyl organophosphate pesticides in
the latter part of pregnancy may be particu-
larly suspect. This is further supported by
the observation that the urinary MDA levels
(parent compound is malathion, a dimethyl
organophosphate) during the latter part of
pregnancy were also associated with signiﬁcant
increased risks for preterm delivery (OR = 5.2,
95% CI, 1.2–22.1, p = 0.03 for levels below
the median; OR = 3.5, 95% CI, 0.9–13.3 p =
0.07 for levels above the median), although
the numbers were small (data not shown).
Nevertheless, the CHAMACOS cohort has a
substantially lower rate of preterm delivery
(6.4%) than that reported for Mexican-born
women in the United States (10%) (Singh
and Yu 1996). This suggests that although our
ﬁndings are biologically intriguing, the poten-
tial effects of pesticides have had little clinical
impact at the population level.
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Table 4. Association of ChE and BChE in maternal blood during pregnancy and at delivery and in umbilical cord blood with length of gestation and fetal growth:
CHAMACOS study, Salinas Valley, California, 2000–2001.
Length of gestation (weeks)b Birth weight (g)c Length (cm)c Head circumference (cm)c Ponderal index (g/cm3)c
No.a β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value β (95% CI) p-Value
ChE (µmol/min/mL)
Maternal blood, pregnancy 340 0.01 (–0.15–0.17) 0.87 8 (–35–52) 0.71 0.05 (–0.20–0.29) 0.72 0.06 (–0.09–0.21) 0.45 0.00 (–0.03–0.03) 0.90
Maternal blood, delivery 357 0.09 (–0.04–0.23) 0.16 6 (–30–43) 0.73 0.05 (–0.17–0.27) 0.67 –0.07 (–0.19–0.05) 0.27 0.00 (–0.03–0.03) 0.95
Cord blood 292 0.34 (0.13–0.55) 0.001** 12 (–46–70) 0.68 –0.01 (–0.36–0.34) 0.95 –0.04 (–0.23–0.14) 0.65 0.02 (–0.03–0.07) 0.43
BChE (µmol/min/mL)
Maternal blood, pregnancy 340 –0.2 (–0.64–0.27) 0.42 56 (–67–179) 0.37 0.07 (–0.63–0.78) 0.83 0.12 (–0.31–0.56) 0.58 0.03 (–0.06–0.12) 0.51
Maternal blood, delivery 357 –0.1 (–0.48–0.36) 0.78 –90 (–206–25) 0.13 0.05 (–0.65–0.75) 0.89 –0.07 (–0.45–0.31) 0.73 –0.07 (–0.16–0.03) 0.16
Cord blood 292 –0.2 (–0.78–0.32) 0.41 111 (–35–257) 0.14 0.23 (–0.65–1.12) 0.6 –0.03 (–0.50–0.45) 0.91 0.05 (–0.07–0.17) 0.45
aNumbers vary slightly for different outcomes due to missing data. bModels adjusted for timing of urine collection, timing of entry into prenatal care, maternal age, parity, country of
birth, and poverty level. cModels adjusted for timing of urine collection, timing of entry into prenatal care, maternal age, parity, infant sex, country of birth, weight gain, BMI, poverty
level, gestational age, and (gestational age)2. *p < 0.10; **p < 0.05.We have no ready explanation for an
increase in some measures of fetal growth (i.e.,
head circumference and crown–heel length) in
relation to pesticide exposure measures. These
results were apparent only after controlling
for gestational age. Berkowitz et al. (2004)
reported a decrease in head circumference
only in those infants whose mothers had low
expression of PON1. Future investigations
will determine whether PON1 status (geno-
type and phenotype) modiﬁes the association
of birth outcomes and pesticide exposure in
the CHAMACOS cohort.
In summary, we have found no adverse
association of in utero organophosphate pesti-
cide exposure and measures of fetal growth,
but a fairly consistent adverse association with
gestational duration. The strengths of this
study include the use of multiple exposure bio-
markers in a large population of women living
in an agricultural community. However, as in
all studies of the effects of pesticide exposure,
we are limited in our ability to accurately
characterize exposure to multiple pesticides
and multiple classes of pesticides over the
course of pregnancy. Nevertheless, given the
importance of premature delivery on the via-
bility and health of the fetus, these findings
warrant further evaluation of the risks associ-
ated with pesticide exposure, especially as
new measures of exposure are developed.
Furthermore, additional research should
determine whether certain subpopulations are
more biologically susceptible to the potential
hazards of organophosphate exposure.
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